Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ahmed K, Koval A, Xu J, Bodmer A, et al. Towards the first targeted therapy for triple-negative breast cancer: repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor. Cancer Lett 2019 Feb 13. pii: S0304-3835(19)30090.
PMID: 30771433


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016